急性B型主动脉夹层灌注不良的腔内开窗/支架治疗
该研究回顾1996至2018年182例因疑诊灌注不良接受腔内开窗/支架治疗的急性B型主动脉夹层患者,中位年龄55岁,住院死亡率7.7%,近8年为0%,新发截瘫0%,5年和10年生存率分别为72%和49%。结论认为该策略短期和长期结果良好,尤其适用于分支血管静态性灌注不良患者。
要点
- 急性B型主动脉夹层合并灌注不良可采用腔内开窗/支架治疗,短期和长期结果良好。
- 该策略尤其适用于主动脉分支血管静态性灌注不良的患者。
- 年龄和急性截瘫是晚期死亡的显著危险因素。
核心结论
- 急性B型主动脉夹层合并灌注不良患者经腔内开窗/支架治疗可获得良好的短期和长期结果。
- 该方法对主动脉分支血管静态性灌注不良患者尤其有帮助。
研究设计与样本
- 回顾性研究,纳入1996年至2018年182例因疑诊灌注不良接受腔内开窗/支架治疗的急性B型主动脉夹层患者。
- 数据来自病历回顾和国家死亡索引数据库。
主要发现
- 患者中位年龄55岁,灌注不良体征包括腹痛61%、下肢无力27%、下肢脉搏不可触及24%。
- 确认的血流动力学显著灌注不良累及脊髓2.7%、腹腔干24%、肠系膜上动脉40%、肾动脉51%、髂股动脉43%。
- 182例中99例(54%)接受主动脉开窗/支架,108例(59%)接受1支或多支分支血管开窗/支架,5例(2.7%)同期行胸主动脉腔内修复,17例(9.3%)附加溶栓或血栓清除术,48例(26%)未接受干预。
- 开窗/支架后24例(13%)因肠坏死或肢体问题需额外手术,9例(4.9%)出院前接受后续主动脉修复(胸主动脉腔内修复或开放修复)。
- 新发截瘫0%,住院死亡率7.7%(20余年期间),近8年为0%,5年和10年生存率分别为72%和49%。
临床怎么用
- 对急性B型主动脉夹层合并灌注不良患者,可考虑腔内开窗/支架治疗以改善分支血管灌注。
- 对分支血管静态性灌注不良患者,该策略尤其有帮助。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study objective was to evaluate the management of malperfusion in acute type B aortic dissection with endovascular fenestration/stenting. METHODS: From 1996 to 2018, 182 patients with an acute type B aortic dissection underwent fenestration/stenting for suspected malperfusion based on imaging, clinical manifestations, and laboratory findings. Data were obtained from medical record review and the National Death Index database. RESULTS: The median age of patients was 55 years. Signs of malperfusion included abdominal pain (61%), lower-extremity weakness (27%), nonpalpable lower-extremity pulses (24%), and abnormal lactate, creatinine, liver enzymes, and creatine kinase levels. Confirmed hemodynamically significant malperfusion affected the spinal cord (2.7%), celiac (24%), superior mesenteric (40%), renal (51%), and iliofemoral (43%) arterial distributions. Of the 182 patients, 99 (54%) underwent aortic fenestration/stenting, 108 (59%) had 1 or multi-branch vessel fenestration/stenting, 5 (2.7%) had concomitant thoracic endovascular aortic repair, 17 (9.3%) had additional thrombolysis or thromboembolectomy, and 48 (26%) received no intervention. After fenestration/stenting, 24 patients (13%) required additional procedures for necrotic bowel or limb and 9 patients (4.9%) had subsequent aortic repair (thoracic endovascular aortic repair, open repair) before discharge. The new-onset paraplegia was 0%. The in-hospital mortality was 7.7% over 20+ years and 0% in the last 8 years. The 5- and 10-year survivals were 72% and 49%, respectively. The significant risk factors for late mortality were age and acute paralysis (hazard ratio, 3.5; both P < .0001). Given death as a competing factor, the 5- and 10-year cumulative incidence of reintervention was 21% and 31% for distal aortic pathology, respectively. CONCLUSIONS: Patients with acute type B aortic dissection with malperfusion can be managed with endovascular fenestration/stenting with excellent short- and long-term outcomes. This approach is particularly helpful to patients with static malperfusion of aortic branch vessels.
引用
- Norton EL, Williams DM, Kim KM, et al. Management of acute type B aortic dissection with malperfusion via endovascular fenestration/stenting. J Thorac Cardiovasc Surg. 2019. PMID: 31669033. doi:10.1016/j.jtcvs.2019.09.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。